Shanghai - Delayed Quote CNY
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (688192.SS)
57.69
+0.26
+(0.45%)
At close: 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Cash Flows from Used in Operating Activities Direct
-762,058.72
-967,882.95
-603,372.72
-492,277.56
-410,012.50
Operating Cash Flow
--
-967,882.95
-603,372.72
-492,277.56
-410,012.50
Investing Cash Flow
81,570.02
611,189.68
384,556.02
-1,627,300.41
-85,042.48
Financing Cash Flow
739,150.19
308,249.11
-33,264.92
1,981,124.26
814,603.92
End Cash Position
127,784.60
73,926.57
121,399.50
363,963.63
508,747.10
Capital Expenditure
-99,916.96
-32,128.12
-73,780.44
-8,984.77
-211,733.33
Issuance of Debt
841,788.90
338,233.41
--
19,540
--
Repayment of Debt
--
--
--
-19,540
--
Free Cash Flow
-861,975.68
-1,000,011.07
-677,153.16
-501,262.34
-621,745.83
12/31/2020 - 12/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade